JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 7, 2002
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
277/24/21315    most recent
M200769200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabbro, M.
Right arrow Articles by Henderson, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabbro, M.
Right arrow Articles by Henderson, B. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 29, 2002
J. Biol. Chem, 10.1074/jbc.M200769200
Submitted on January 24, 2002
Revised on March 29, 2002
Accepted on March 29, 2002

BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export

Megan Fabbro, Jose A. Rodriguez, Richard Baer, and Beric R. Henderson

Westmead Institute for Cancer Research, University of Sydney, Sydney, NSW 2145

Corresponding Author: beric_henderson{at}wmi.usyd.edu.au

BRCA1 is a tumor suppressor with several important nuclear functions. BRCA1 has no known cytoplasmic functions. We show here that the two previously identified nuclear localization signals (NLSs) are insufficient for nuclear localization of BRCA1 due to the opposing action of an N-terminal nuclear export signal (NES). In transfected breast cancer cells, BRCA1 nuclear localization requires both the NLSs and the N-terminal RING domain region; mutating either of these sequences shifts BRCA1 to the cytoplasm. The BRCA1 RING element mediates nuclear import via association with BARD1, and this is not affected by cancer-associated RING mutations. Moreover, BARD1 directly masks the BRCA1 NES, and the resulting block to nuclear export is requisite for efficient import and nuclear localization of ectopic and endogenous BRCA1. Our results explain why BRCA1 exon 11 splice variants, which lack the NLSs but retain the RING domain, are frequently detected in the nucleus and in nuclear foci in vivo. In fact, co-expression of BARD1 promoted formation of DNA damage-induced nuclear foci comprising ectopic wild-type or NLS-deficient BRCA1, implicating BARD1 in nuclear targeting of BRCA1 for DNA repair. Our identification of BARD1 as a BRCA1 nuclear chaperone has regulatory implications for its reported effects on BRCA1 protein stability, ubiquitin ligase activity and DNA repair.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Li, S. Ryser, E. Dizin, D. Pils, M. Krainer, C. E. Jefford, F. Bertoni, R. Zeillinger, and I. Irminger-Finger
Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers
Cancer Res., December 15, 2007; 67(24): 11876 - 11885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Laufer, S. V. Nandula, A. P. Modi, S. Wang, M. Jasin, V. V. V. S. Murty, T. Ludwig, and R. Baer
Structural Requirements for the BARD1 Tumor Suppressor in Chromosomal Stability and Homology-directed DNA Repair
J. Biol. Chem., November 23, 2007; 282(47): 34325 - 34333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Tembe and B. R. Henderson
BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis
J. Biol. Chem., July 13, 2007; 282(28): 20513 - 20522.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Lu, A. Amleh, J. Sun, X. Jin, S. D. McCullough, R. Baer, D. Ren, R. Li, and Y. Hu
Ubiquitination and Proteasome-Mediated Degradation of BRCA1 and BARD1 during Steroidogenesis in Human Ovarian Granulosa Cells
Mol. Endocrinol., March 1, 2007; 21(3): 651 - 663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Colnaghi, C. M. Connell, R. M. A. Barrett, and S. P. Wheatley
Separating the Anti-apoptotic and Mitotic Roles of Survivin
J. Biol. Chem., November 3, 2006; 281(44): 33450 - 33456.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P K Lovelock, S Healey, W Au, E Y M Sum, A Tesoriero, E M Wong, S Hinson, R Brinkworth, A Bekessy, O Diez, et al.
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants
J. Med. Genet., January 1, 2006; 43(1): 74 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer
Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells
J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tatematsu, N. Yoshimoto, T. Koyanagi, C. Tokunaga, T. Tachibana, Y. Yoneda, M. Yoshida, T. Okajima, K. Tanizawa, and S. Kuroda
Nuclear-Cytoplasmic Shuttling of a RING-IBR Protein RBCK1 and Its Functional Interaction with Nuclear Body Proteins
J. Biol. Chem., June 17, 2005; 280(24): 22937 - 22944.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Thompson, C. L. Robinson-Benion, and J. T. Holt
An Amino-terminal Motif Functions as a Second Nuclear Export Sequence in BRCA1
J. Biol. Chem., June 10, 2005; 280(23): 21854 - 21857.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
F. Al-Mulla, M. Abdulrahman, G. Varadharaj, N. Akhter, and J. T. Anim
BRCA1 Gene Expression in Breast Cancer: A Correlative Study between Real-time RT-PCR and Immunohistochemistry
J. Histochem. Cytochem., May 1, 2005; 53(5): 621 - 629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Schuchner, V. Tembe, J. A. Rodriguez, and B. R. Henderson
Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1
J. Biol. Chem., March 11, 2005; 280(10): 8855 - 8861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. W. Y. Au and B. R. Henderson
The BRCA1 RING and BRCT Domains Cooperate in Targeting BRCA1 to Ionizing Radiation-induced Nuclear Foci
J. Biol. Chem., February 25, 2005; 280(8): 6993 - 7001.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S-M Karppinen, K Heikkinen, K Rapakko, and R Winqvist
Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer
J. Med. Genet., September 1, 2004; 41(9): e114 - e114.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Feng, L. Kachnic, J. Zhang, S. N. Powell, and F. Xia
DNA Damage Induces p53-dependent BRCA1 Nuclear Export
J. Biol. Chem., July 2, 2004; 279(27): 28574 - 28584.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takano, S. Adachi, M. Okuno, Y. Muto, T. Yoshioka, R. Matsushima-Nishiwaki, H. Tsurumi, K. Ito, S. L. Friedman, H. Moriwaki, et al.
The RING Finger Protein, RNF8, Interacts with Retinoid X Receptor {alpha} and Enhances Its Transcription-stimulating Activity
J. Biol. Chem., April 30, 2004; 279(18): 18926 - 18934.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. R. Morris and E. Solomon
BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair
Hum. Mol. Genet., April 15, 2004; 13(8): 807 - 817.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
U. K. Westermark, M. Reyngold, A. B. Olshen, R. Baer, M. Jasin, and M. E. Moynahan
BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks
Mol. Cell. Biol., November 1, 2003; 23(21): 7926 - 7936.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Staff, J. Isola, and M. Tanner
Haplo-insufficiency of BRCA1 in Sporadic Breast Cancer
Cancer Res., August 15, 2003; 63(16): 4978 - 4983.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
T I Orban and E Olah
Emerging roles of BRCA1 alternative splicing
Mol. Pathol., August 1, 2003; 56(4): 191 - 197.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. E. McCarthy, J. T. Celebi, R. Baer, and T. Ludwig
Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability
Mol. Cell. Biol., July 15, 2003; 23(14): 5056 - 5063.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Benezra, N. Chevallier, D. J. Morrison, T. K. MacLachlan, W. S. El-Deiry, and J. D. Licht
BRCA1 Augments Transcription by the NF-{kappa}B Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit
J. Biol. Chem., July 11, 2003; 278(29): 26333 - 26341.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. S. Brzovic, J. R. Keeffe, H. Nishikawa, K. Miyamoto, D. Fox III, M. Fukuda, T. Ohta, and R. Klevit
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex
PNAS, May 13, 2003; 100(10): 5646 - 5651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xia, G. M. Pao, H.-W. Chen, I. M. Verma, and T. Hunter
Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein
J. Biol. Chem., February 7, 2003; 278(7): 5255 - 5263.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.